by Prakash Achaary | Sep 22, 2021 | News
CANTON, Mich. (September 22, 2021) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced the release of SmartStart™ Tech-Enabled Templates to reduce time and effort in the document content creation process while increasing the...
by Prakash Achaary | Sep 15, 2021 | Blog
Why is drug development and research in the context of rare disease frequently more difficult to address? In this blog, we will outline some of the challenges with rare disease programs. What is a rare disease? Simply put, a rare disease or condition is one that...
by Prakash Achaary | Aug 31, 2021 | Blog
For Sponsors planning to manufacture or distribute a medical device in the US, understanding regulatory requirements is of the utmost importance. Medical device development and approval are regulated by the FDA, under the jurisdiction of the Center for Devices and...
by Prakash Achaary | Aug 31, 2021 | Blog
How to Train Users on the Clinical Trial Information System (CTIS) Ahead of New Regulations On 31 July 2021, the European Commission published a notice in the Official Journal of the European Union announcing that the EU Portal and Database, a key component of the...
by Prakash Achaary | Aug 16, 2021 | Blog
For its leadership and culture as a clinical research organization (CRO) in the pharmaceutical industry, MMS has received much recognition and praise recently. To uncover some of the reasons behind this success, we recently sat down with Prasad M. Koppolu, Chief...
